People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Integrated Diagnostics, Inc. | — | Biotechnology | Series B | $45.3M | $242.1M | 2014 |
| Achieve Life Sciences, Inc. | — | Biotechnology | Series B | $28.9M | $269.7M | 2022 |
| Allozyne Inc | — | Biotechnology | Seed | $8.2M | $108.9M | 2012 |
John Bencich at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Bencich on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jay Moyes | 2 | 2 |
| Steven Gillis | 1 | 23 |
| Arnold Oronsky | 1 | 10 |
| Michael Liang | 1 | 9 |
| Stephen Davis | 1 | 8 |
| Carl Weissman | 1 | 8 |
| David Barker | 1 | 7 |
| Leroy Hood | 1 | 5 |
| James Heath | 1 | 5 |
| Michael Steinmetz | 1 | 4 |
| Douglas Sanders | 1 | 2 |
| Donald Joseph | 1 | 2 |
| Meenu Chhabra | 1 | 2 |
| Albert Luderer | 1 | 2 |
| Michael A. Martino | 1 | 2 |
| Cindy Jacobs | 1 | 2 |
| Anthony Clarke | 1 | 2 |
| Kenneth Fang | 1 | 1 |
| Jaime Xinos | 1 | 1 |
| Kenneth Grabstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.